Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11527 posts found.

Janssen sales follow J&J’s downward trend

July 15, 2015 Sales and Marketing J&J, JJ, Johnson & Johnson, Johnson and Johnson, financial results, olysio

Strong sales of its new hepatitis C treatment Olysio were not enough to stop a slump in profits at J&J’s …
News

Celgene to acquire Receptos in $7.2bn deal

July 15, 2015 Sales and Marketing Celgene, Crohn's, Crohn’s disease, Receptos, acquisitions, crohn's disease, mergers, multiple sclerosis, ozanimod, relapsing multiple sclerosis, ulcerative colitis

Celgene has boosted its immune and inflammatory disease pipeline with the purchase of the biopharma company Receptos for $7.2 billion. …
News

Ergomed strengthens management team and board

July 15, 2015 Research and Development, Sales and Marketing Andrew Mackie, ergomed

UK-based drug development company Ergomed has appointed Andrew Mackie as chief business officer, and to its board as executive director.Mackie …
Appointment

FDA approves Lundbeck and Otsuka’s Rexulti for depression

July 14, 2015 Sales and Marketing FDA, Lundbeck, Otsuka, Rexulti, US, brexpiprazole, depression, major depressive disorder, schizophrenia

Lundbeck and Otsuka have gained a yes vote from the FDA for their jointly-marketed antidepressant, Rexulti. The US regulator approved …
News

Diary of a decade – Ten years in Europe, the Middle East and Africa

July 13, 2015 Medical Communications, Sales and Marketing Astellas, Ken Jones

It’s hard to imagine how much a company can change in a decade.When Astellas Pharma Europe was launched 10 years …
Feature

NICE recommends Daiichi’s Lixiana for blood clots

July 13, 2015 Sales and Marketing DVT, Daiichi, Daiichi Sankyo, Lixiana, NICE, NOACs, VTE, anticoagulant, blood clots, edoxaban, novel anticoagulant. PE

Daiichi Sankyo has won a speedy approval from NICE, after the NHS guidance body approved its newly-launched blood clotting drug …
News

Pharma dominates global M&A activity

July 10, 2015 Sales and Marketing M&A, MA, acquisitions, mergers, takeovers

Mergers and acquisitions in the pharma, medical and biotech sectors have hit the highest levels in nearly 15 years, a …
News

NICE u-turns on Entyvio for Crohn’s disease

July 10, 2015 Medical Communications, Sales and Marketing Crohn's, Crohn’s disease, Entyvio, Millenium, NICE, Takeda, funding

NICE has performed a u-turn and recommended drug treatment Entyvio for Crohn’s disease for routine NHS funding.In final draft guidance …
News

Daiichi Sankyo launches clotting drug Lixiana in UK

July 10, 2015 Medical Communications, Sales and Marketing Daiichi Sankyo, Lixiana, NOAC, VTE, anticoagulant, atrial fibrillation, blood clots, edoxaban, novel anticoagulant, strokes, warfarin

Daiichi Sankyo’s Lixiana has become the latest pharma offering in the class of newer oral anticoagulants in the UK.Lixiana (edoxaban) …
News

Horizon attempts a hostile $3bn Depomed takeover

July 9, 2015 Manufacturing and Production, Research and Development, Sales and Marketing Depomed, M&A, MA, acquisitions, horizon, mergers, takeover

Dublin-based specialty pharmaceutical company Horizon has launched a bid to buy Depomed for $3 billion. Horizon, a biopharma company focussed …
News

Novartis wins US nod for new heart drug

July 8, 2015 Research and Development, Sales and Marketing Entestro, FDA, LCZ696, Novartis, ejection fraction, heart failure, reduced ejection fraction, sacubitril

The FDA has given the green light to Novartis’ new heart failure drug, six weeks ahead of the scheduled date …
News

European medicines group appoints Bayer’s Alex Moscho as new chair

July 7, 2015 Manufacturing and Production, Research and Development, Sales and Marketing Alexander Moscho, EMG, European Medicines Group

Leading UK industry group the European Medicines Group (EMG) has elected Dr Alexander Moscho, the managing director of Bayer UK …
Appointment

Pharma ‘paid US doctors $1.5 billion’ in 2014

July 7, 2015 Medical Communications, Sales and Marketing Sunshine Act, US, pharma

Some of the largest European drugmakers paid US doctors and teaching hospitals $1.5 billion in 2014 to participate in promotional …
News

Teva ‘to increase Mylan bid to $43bn’

July 7, 2015 Sales and Marketing M&A, MA, Mylan, Teva, generics

Israeli drugmaker Teva is considering whether to up its bid for US rival firm Mylan, with reports that it could …
News

Prescribing in England up 55% to £9bn over a decade

July 7, 2015 Manufacturing and Production, Sales and Marketing NHS, NHSIC, drugs, health and social care information centre, net ingredient cost, prescribing

The number of drugs issued in England continues to soar, according to the latest NHS figures which show prescribing in …
News
The Gateway to Local Adoption Series

Latest content

Scots neonatal innovations target hearing loss and earlier care

August 28, 2026

FDA grants De Novo authorisation to light-filtering device for migraine

August 28, 2026

Southgate opens Innovation Lab for logistics and fulfilment development

August 27, 2026

Bioptimus partners with Cancer Research Horizons to expand AI cancer data set

August 27, 2026

Agentis Health Group acquires Clinical Pharmacist Solutions

August 26, 2026